Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Exscientia

Professor Andrew L. Hopkins appointed Commander of the Order of the British Empire (CBE)
From Exscientia
Via Business Wire
Tickers EXAI
Exscientia to Report Second Quarter 2023 Financial Results on August 10, 2023
From Exscientia
Via Business Wire
Tickers EXAI
Exscientia Initiates Prospective Observational Study in Ovarian Cancer
From Exscientia
Via Business Wire
Tickers EXAI
Exscientia Announces Expansion of its Technology Leadership Team
From Exscientia
Via Business Wire
Tickers EXAI
Exscientia Business and Financial Update for the Full Year 2022
From Exscientia
Via Business Wire
Tickers EXAI
Exscientia to Present at Upcoming Investor Conferences in November
From Exscientia
Via Business Wire
Tickers EXAI
Blood Cancer Discovery Publication Further Validates Exscientia's AI Precision Medicine Platform for Improving Patient Outcomes
From Exscientia
Via Business Wire
Tickers EXAI
Exscientia to Present at Upcoming Investor Conferences in September
From Exscientia
Via Business Wire
Tickers EXAI
Exscientia to Report Second Quarter 2022 Financial Results on August 17, 2022
From Exscientia
Via Business Wire
Tickers EXAI
Exscientia to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference
From Exscientia
Via Business Wire
Tickers EXAI
Exscientia to Report First Quarter 2022 Financial Results on May 25, 2022
From Exscientia
Via Business Wire
Tickers EXAI
Exscientia to Present at the BofA Securities 2022 Healthcare Conference
From Exscientia
Via Business Wire
Tickers EXAI
Michael Krams, M.D., Joins Exscientia as Chief Quantitative Medicine Officer
From Exscientia
Via Business Wire
Tickers EXAI
Exscientia to Report Fourth Quarter and Year End 2021 Financial Results on March 23, 2022
From Exscientia
Via Business Wire
Tickers EXAI
Exscientia to Present at Upcoming Investor Conferences in March
From Exscientia
Via Business Wire
Tickers EXAI
Professor Charlotte Deane Joins Exscientia as Chief Scientist of Biologics AI
From Exscientia
Via Business Wire
Tickers EXAI
Exscientia and Sanofi Establish Strategic Research Collaboration to Develop AI-driven Pipeline of Precision-Engineered Medicines
From Exscientia
Via Business Wire
Tickers EXAI
Exscientia to Present at Evercore ISI 4th Annual HealthCONx Virtual Conference
From Exscientia
Via Business Wire
Tickers EXAI
Exscientia Business Update for Third Quarter 2021
From Exscientia
Via Business Wire
Tickers EXAI
Exscientia to Report Third Quarter 2021 Financial Results on November 17, 2021
From Exscientia
Via Business Wire
Tickers EXAI
Publication of EXALT-1 Trial in Cancer Discovery Demonstrates First AI-Supported Functional Precision Medicine Platform to Improve Cancer Treatment Outcomes
From Exscientia
Via Business Wire
Tickers EXAI
Exscientia Announces Closing of $510.4 Million Aggregate Financing, Consisting of $350.4 Million Upsized Initial Public Offering With Full Exercise of Underwriters’ Option to Purchase Additional ADSs and $160.0 Million Concurrent Private Placement
From Exscientia
Via Business Wire
Tickers EXAI
Exscientia Enters $70M Collaboration to Develop Antiviral Therapeutics Against Coronavirus and Other Viruses With Pandemic Potential
From Exscientia
Via Business Wire
Bristol Myers Squibb Exercises Option to Develop Exscientia’s AI-designed, Immune-modulating Drug Candidate
From Exscientia
Via Business Wire
Exscientia Builds Automated Laboratories in Oxford to Expand Pipeline
From Exscientia
Via Business Wire
Exscientia and GT Apeiron Therapeutics Enter Oncology Joint Venture
From Exscientia
Via Business Wire
Exscientia Accelerates COVID-19 Drug Discovery Using AI
From Exscientia
Via Business Wire
Exscientia Acquires Personalised Medicine AI Pioneer Allcyte
From Exscientia
Via Business Wire
Exscientia announces multi-target, AI-driven drug discovery collaboration with Bristol Myers Squibb
From Exscientia
Via Business Wire
Exscientia Announces Investment of up to $525M
From Exscientia
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.